28 reports

  • MARKET OUTLINE

Endoscopy cameras segment accounts for a major share owing to its widespread usage in diagnostic and therapeutic applications in fields of gastrointestinal (GI) endoscopy, laparoscopy, arthroscopy, laryngoscopy, bronchoscopy, and many other diagnostic and therapeutic procedures.

  • Camera
  • Dermatology
  • Market Size
  • Olympus Corporation
  • Stryker Corporation
  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, APPROVED DERMATOLOGY INDICATIONS FOR
  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, CO-DEVELOPMENT DEALS, 2006-2017 (PART

Minor AEs such as stomatitis, headaches, fatigue and gastrointestinal problems such as nausea and vomiting may occur when using Metolate.

  • Dermatology
  • World
  • AbbVie Inc.
  • Allergan plc
  • Amgen Inc.

ORAL MEDICATIONS THAT INCLUDE ANTIBIOTICS AND RETINOIDS HAVE LED TO INCREASED HEPATOTOXICITY, GASTROINTESTINAL ISSUES AND SUICIDAL TENDENCIES, ALONG WITH THE ABOVE MENTIONED ISSUES.

  • Dermatology
  • World
  • Forecast
  • Allergan plc
  • Valeant Pharmaceuticals International, Inc.
  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, OVERALL PHARMACEUTICAL INDUSTRY
  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, APPROVED DERMATOLOGY INDICATIONS

Minor AEs such as stomatitis, headaches, fatigue and gastrointestinal problems such as nausea and vomiting may occur when using methotrexate.

  • Dermatology
  • World
  • Market Size
  • Amgen Inc.
  • Biologics, Inc.
  • Dermatology Therapeutics Market, Global, Overall
  • Dermatology Therapeutics Market, Global, Pipeline Programs Targeting ORAI1, 2017

It is also in development for various indications in the gastrointestinal, respiratory, and ophthalmology therapy areas.

  • Dermatology
  • World
  • Market Size
  • Allergan plc
  • Apricus Biosciences, Inc.

RISK FACTORS severe acne was related to a higher prevalence of one or more gastrointestinal, sinopulmonary, and psychological co-morbid disorders.

  • Dermatology
  • Allergan plc
  • Foamix Ltd.
  • GlaxoSmithKline plc
  • Novartis AG

RISK FACTORS severe acne was related to a higher prevalence of one or more gastrointestinal, sinopulmonary, and psychological co-morbid disorders.

  • Dermatology
  • Allergan plc
  • Foamix Ltd.
  • GlaxoSmithKline plc
  • Novartis AG

Allergy, photosensitivity, gastrointestinal disturbance, and vaginal candidiasis are some of the side effects and risks with oral antibiotics therapy.

  • Dermatology
  • India
  • Allergan plc
  • Cipla Ltd
  • Novartis AG
  • Research Contact: info@globaldata.com

The gastrointestinal therapeutics market recorded ## partnership deals and six licensing deals worth USD##. ## billion in Q## 2016.

  • Dermatology
  • Endocrine Disease
  • World
  • Deals & Alliance
  • AstraZeneca PLC
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2017 (CONTD..1), H1 2017

NA : Not Available Source: Global Markets Direct RECOMBINANT PROTEIN FOR SCAR - DRUG PROFILE RECOMBINANT PROTEIN TO ANTAGONIZE TGF BETA FOR IMMUNOLOGY, DERMATOLOGY, GASTROINTESTINAL AND MUSCULOSKELETAL DISORDERS - DRUG PROFILE RXI-## - DRUG PROFILE ## resulted in dose-dependent silencing

  • Dermatology
  • United States
  • World
  • Product Initiative
  • RXi Pharmaceuticals Corporation
  • Almirall SA, Deals By Therapy Area, 2011 to YTD 2017

Under the agreement, Almirall obtained the commercialization rights to Linaclotide in Mexico, for the treatment of IBS-C and other gastrointestinal conditions.

  • Dermatology
  • Europe
  • Spain
  • Company Financials
  • Almirall, S.A.
  • Maruho Acquires Dermatology Company, Cutanea Life Sciences

The company also offers products for infectious disease, ear nose throat disorders, ophthalmology, musculoskeletal disorders, central nervous system (CNS) disorders, cardiovascular, gastrointestinal and other diseases.

  • Dermatology
  • Pharmaceutical
  • Japan
  • United States
  • Maruho Co., Ltd.

It promotes acquired and licensed prescription products across various therapeutic categories such as dermatology, central nervous system, women' s health, infectious disease, cardiovascular, respiratory, immunology, gastrointestinal, oncology, nutrition, toxicology, and mouth and denta

  • Dermatology
  • Healthcare
  • Wound Care
  • United States
  • Product Initiative

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Dermatology
  • Type 2 Diabetes
  • United States
  • Company
  • Product Initiative
  • Valeant Pharmaceuticals International Inc, Deals By Therapy Area, 2011 to YTD 2017

CAROLYN LOGAN, PRESIDENT AND CEO, SALIX, SAID, " WE BELIEVE GASTROINTESTINAL-SPECIFIC ORAL ANTIBIOTIC RIFAXIMIN HAS THE POTENTIAL TO TREAT NUMEROUS GASTROINTESTINAL DISEASES.

  • Ambulatory Care
  • Dermatology
  • Canada
  • United States
  • Valeant Pharmaceuticals International, Inc.

Endoscopic data reflect the ability of Brilacidin to help clear Gastrointestinal (GI) tract mucosa in patients suffering from ulcerative colitis.

  • Anti-Infective
  • Dermatology
  • Pharmaceutical
  • United States
  • Product Initiative

The company also offers products for infectious disease, ear nose throat disorders, ophthalmology, musculoskeletal disorders, central nervous system (CNS) disorders, cardiovascular, gastrointestinal and other diseases.

  • Dermatological Condition
  • Dermatology
  • United States
  • Company
  • Dermira, Inc.

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Dermatology
  • United States
  • Product Initiative
  • Supply
  • Dermira, Inc.

Endoscopic data reflect the ability of Brilacidin to help clear Gastrointestinal (GI) tract mucosa in patients suffering from ulcerative colitis.

  • Dermatology
  • Hospital
  • United States
  • Product Initiative
  • Cellceutix Corporation
  • VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (FORMERLY BIOVAIL CORPORATION)
  • COMPANY OVERVIEW AND KEY FACTS

Salix is a US-based pharmaceutical company focused on treatment of gastrointestinal diseases, while Dr.

  • Dermatology
  • United States
  • Company
  • M&A
  • Valeant Pharmaceuticals International, Inc.

Gastrointestinal Tract Cancer, Inflammation, Inflammatory Bowel Disease, Inflammatory Pain, Lung Cancer, Osteoarthritis Pain Planned Phase I/ II Interventional AAT-## AskAt Inc.

  • Dermatological Condition
  • Dermatology
  • Pathology
  • World
  • Product Initiative

Gastrointestinal Disorders Completed Phase I Interventional CNDO-## Beth Israel Deaconess Medical Center Inc Food Allergy Initiative ## Feb 2010 ## Dec 2011 ## ## ## Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Trial Statu

  • Clinical Trial
  • Dermatology
  • Pharmaceutical
  • World
  • Product Initiative
  • Clinical Trial profile. 155 Trial Title
  • Clinical Trial Profile Snapshots

Gastrointestinal Tumor, Trauma (CD##/ CD##, Interleukin ## (T Cell Growth Factor or Aldesleukin or IL##), Interleukin ## (B Cell Stimulatory Factor ## or Binetrakin or Lymphocyte Stimulatory Factor ## or Pitrakinra or IL##), Natural Killer (NK) Cell, T Cell Surface Glycoprotein CD## (T Cell Surf

  • Dermatology
  • Hospital
  • Therapy
  • World
  • Product Initiative

The company intends to use the proceeds to add more data analysis to its products and move into new specialty areas including gastrointestinal care, ENT care and rheumatology.

  • Dermatology
  • Patient Data Management
  • United States
  • Company
  • Modernizing Medicine, Inc.

Gastrointestinal Disorders, Peanut Allergy, Pruritus, Rhino-Conjunctivitis Completed Phase I Interventional CNDO-## Beth Israel Deaconess Medical Center, Inc.

  • Clinical Trial
  • Dermatology
  • Pharmaceutical
  • World
  • Product Initiative

gastrointestinal disorder, eye health, neurology and branded generics.

  • Dermatology
  • United States
  • Company
  • M&A
  • Valeant Pharmaceuticals International, Inc.

Gastrointestinal Tract Cancer, Inflammation, Inflammatory Bowel Disease, Inflammatory Pain, Lung Cancer, Osteoarthritis Pain Planned Phase I/ II Interventional AAT-## AskAt Inc.

  • Clinical Trial
  • Dermatological Condition
  • Dermatology
  • World
  • Novartis AG

The company focuses on pharmaceutical products in therapeutics, including prescription drugs for gastrointestinal, respiratory, and cardiovascular indications, as well as on OTC medication.

  • Dermatology
  • United States
  • Corporate Finance
  • M&A
  • Peplin, Inc.